SEC Form D filing

Memento Medicines, Inc., 2026-06-16

An SEC Form D private-offering notice from Boston, MA, a $93,000,383 filer-stated offering target in Biotech. Filed 2026-06-16. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Memento Medicines, Inc. Verified via SEC Form D

Boston biotech developing a Tie2 agonist and VEGF inhibitor bispecific antibody for retinal diseases including wet AMD and diabetic macular edema.

Filed 2026-06-16Filed to raise $93,000,383First money in 2026-06-03Raised so far $38,000,159HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source